A 66-year-old man with COPD (FEV1 45% predicted) has had two exacerbations in the last year despite using salbutamol PRN. He is a non-smoker now. No a...

Question

A 66-year-old man with COPD (FEV1 45% predicted) has had two exacerbations in the last year despite using salbutamol PRN. He is a non-smoker now. No asthma features. What inhaled therapy should be added next?

Accepted Answer

Long-acting muscarinic antagonist (LAMA)

Answer

Inhaled corticosteroid (ICS) monotherapy

Answer

Long-acting beta2-agonist (LABA) alone

Answer

LABA + ICS combination

Answer

Oral theophylline

ukmla MCQ (SBA): COPD maintenance therapy

A 66-year-old man with COPD (FEV1 45% predicted) has had two exacerbations in the last year despite using salbutamol PRN. He is a non-smoker now. No asthma features. What inhaled therapy should be added next?